$750,000 Uses in New Management Investors Financing Clause

New Management Investors Financing from Restructuring Agreement

This Master Restructuring Agreement is made as of this 10th day of July, 2008 by and among ADUROMED INDUSTRIES, INC. (formerly General Devices, Inc., "ADRM"), ADUROMED CORPORATION ("Aduromed"), SHERLEIGH ASSOCIATES INC. DEFINED BENEFIT PENSION PLAN ("Sherleigh"), PEQUOT CAPITAL MANAGEMENT, INC. ("Pequot"), on behalf of PEQUOT SCOUT FUND, L.P., PEQUOT MARINER MASTER FUND, L.P., PEQUOT NAVIGATOR OFFSHORE FUND, INC., PEQUOT DIVERSIFIED MASTER FUND, LTD., and PREMIUM SERIES PCC LIMITED CELL 33 (collectively, the "Pequot Funds"), HELLER CAPITAL INVESTMENTS ("Heller") and the individuals and entities listed on Schedule A attached hereto identified as the "Polak/Lazar Secured Parties" (the Polak/Lazar Secured Parties together with Heller are collectively referred to herein as the "Bridge Loan Holders").

New Management Investors Financing. Esposito agrees to invest at least $250,000 and cause the other New Management Investors to invest up to an additional $750,000 into ADRM in two traunches, with the closing of traunch 1 to occur on July 10, 2008 and the closing of traunch 2 to occur as soon as possible but no later than the Effective Time. It is understood that said best efforts may not result in an additional funding being secured and as such Esposito is not responsible for the additional funding contemplated should this situation arise. The parties hereto hereby agree that the terms of any financing by New Management Investors shall (i) be for 80,000,000 shares of Common Stock for $1,000,000 invested, and (ii) include warrants to purchase Common Stock at an exercise price of $0.025 per share at a ratio of 1:1 with the shares of Common Stock issued in such financing. Such warrants shall have anti-dilution protection equivalent to the Preferred Warrants and the Bridge Warrants as amended after the Effective Time, and shall otherwise include equivalent terms as the Preferred Warrants and the Bridge Warrants and such financing shall be evidenced by normal and customary documents for public company common stock financings. The actual shares will be calculated based upon the total money raised by New Management Investors. Esposito shall fund traunch 1 in the amounts as are set forth opposite their names on Schedule B attached hereto by wire transferring funds into a bank account provided by ADRM. In connection with the closing of traunch 1 ADRM shall issue to Esposito Common Stock certificates for the number of shares and shall issue common stock purchase warrants for the number of shares as are set forth next to their names on Schedule B. ADRM hereby agrees to take any and all necessary or appropriate actions to issue and register pursuant to the Securities Act of 1933 the Common Stock contemplated to be issued pursuant to the New Management Investment (including, without limitation, shares issuable upon exercise of the warrants) such that such shares of Common Stock may be offered and resold from time to time, and to take any and all necessary or appropriate actions to keep in effect any and all registration statements covering such shares of Common Stock.

New Management Investors Financing from Restructuring Agreement

This Master Restructuring Agreement is made as of this 10th day of July, 2008 by and among ADUROMED INDUSTRIES, INC. (formerly General Devices, Inc., "ADRM"), ADUROMED CORPORATION ("Aduromed"), SHERLEIGH ASSOCIATES INC. DEFINED BENEFIT PENSION PLAN ("Sherleigh"), PEQUOT CAPITAL MANAGEMENT, INC. ("Pequot"), on behalf of PEQUOT SCOUT FUND, L.P., PEQUOT MARINER MASTER FUND, L.P., PEQUOT NAVIGATOR OFFSHORE FUND, INC., PEQUOT DIVERSIFIED MASTER FUND, LTD., and PREMIUM SERIES PCC LIMITED CELL 33 (collectively, the "Pequot Funds"), HELLER CAPITAL INVESTMENTS ("Heller") and the individuals and entities listed on Schedule A attached hereto identified as the "Polak/Lazar Secured Parties" (the Polak/Lazar Secured Parties together with Heller are collectively referred to herein as the "Bridge Loan Holders").

New Management Investors Financing. Esposito agrees to invest at least $250,000 and cause the other New Management Investors to invest up to an additional $750,000 into ADRM in two traunches, with the closing of traunch 1 to occur on July 10, 2008 and the closing of traunch 2 to occur as soon as possible but no later than the Effective Time. It is understood that said best efforts may not result in an additional funding being secured and as such Esposito is not responsible for the additional funding contemplated should this situation arise. The parties hereto hereby agree that the terms of any financing by New Management Investors shall (i) be for 80,000,000 shares of Common Stock for $1,000,000 invested, and (ii) include warrants to purchase Common Stock at an exercise price of $0.025 per share at a ratio of 1:1 with the shares of Common Stock issued in such financing. Such warrants shall have anti-dilution protection equivalent to the Preferred Warrants and the Bridge Warrants as amended after the Effective Time, and shall otherwise include equivalent terms as the Preferred Warrants and the Bridge Warrants and such financing shall be evidenced by normal and customary documents for public company common stock financings. The actual shares will be calculated based upon the total money raised by New Management Investors. Esposito shall fund traunch 1 in the amounts as are set forth opposite their names on Schedule B attached hereto by wire transferring funds into a bank account provided by ADRM. In connection with the closing of traunch 1 ADRM shall issue to Esposito Common Stock certificates for the number of shares and shall issue common stock purchase warrants for the number of shares as are set forth next to their names on Schedule B. ADRM hereby agrees to take any and all necessary or appropriate actions to issue and register pursuant to the Securities Act of 1933 the Common Stock contemplated to be issued pursuant to the New Management Investment (including, without limitation, shares issuable upon exercise of the warrants) such that such shares of Common Stock may be offered and resold from time to time, and to take any and all necessary or appropriate actions to keep in effect any and all registration statements covering such shares of Common Stock.